Neuroimaging and Psychosocial Addiction Treatment
Palgrave Macmillan (Verlag)
978-1-137-36264-3 (ISBN)
Bryon Adinoff, VA North Texas Health Care System and UT Southwestern Medical Center, USA Nicholas L. Balderston, National Institute of Mental Health, National Institutes of Health, USA Mera S. Barr, MSc, University of Toronto, Canada Warren K. Bickel, Virginia Tech Carilion Research Institute, USA Daniel M. Blumberger, University of Toronto, Canada David B. Brown, University of New Mexico, USA Kathleen M. Carroll, Yale University School of Medicine, USA Anna Rose Childress, University of Pennsylvania, USA Kelly E. Courtney, University of California, USA Janna Cousijn, Utrecht University , the Netherlands Anita Cservenka, Oregon Health & Science University, USA Zafiris J. Daskalakis, University of Toronto, Canada Monique Ernst, National Institute of Mental Health, National Institutes of Health, USA Sarah W. Feldstein Ewing, University of New Mexico, USA Francesca M. Filbey, University of Texas at Dallas, USA Teresa R. Franklin, University of Pennsylvania, USA Hugh Garavan, Universityof Vermont, USA Tony P. George, University of Toronto, Canada Elizabeth A. Hale, National Institute of Mental Health, National Institutes of Health, USA Jon M. Houck, University of New Mexico, USA Kent E. Hutchison, University of Pennsylvania, USA David P. Jarmolowicz, University of Kansas, USA Hollis C. Karoly, University of Colorado Boulder, USA Ariel Ketcherside, University of Texas at Dallas, USA Karen A. Miotto, University of California, USA Joel Mumma, Georgia Institute of Technology, USA Bonnie J. Nagel, Oregon Health & Science University, USA Tam T. Nguyen-Louie, San Diego State University, USA Tomá Paus, University of Toronto, Canada Zdenka Pausova, Senior Scientist, University of Toronto Matthew R. Pearson, University of New Mexico, USA Marc N. Potenza, Yale School of Medicine, USA Rachel A. Rabin, University of Toronto, Canada Lara A. Ray, University of California, USA Derek D. Reed, University of Kansas, USA Daniel J. O. Roche, University of California, USA Corey R. Roos,University of New Mexico,USA Joseph P. Schacht, Medical University of South Carolina, USA Catherine Stanger, Geisel School of Medicine at Dartmouth, USA Susan F. Tapert, VA San Diego Healthcare System, USA Salvatore Torrisi, National Institute of Mental Health, National Institutes of Health, USA Reagan R. Wetherill, University of Pennsylvania, USA Claire E. Wilcox, University of New Mexico, USA Stephen J. Wilson, The Pennsylvania State University, USA Katie Witkiewitz, University of New Mexico, USA Sarah W. Yip, Yale School of Medicine, USA
"Preface
PART I: INTRODUCTION
1. Translational Approaches to Addiction Treatment; Sarah W. Yip, Kathleen M. Carroll and Marc N. Potenza
2. Fundamentals of Addiction Neuroscience; Ariel Ketcherside and Francesca M. Filbey
PART II: TRANSLATIONAL APPROACHES WITH ADULTS
3. Using Clinical Neuroscience to Understand Addiction Treatment; Joseph P. Schacht and Kent E. Hutchison
4. Neuropsychopharmacology in Addiction Treatment; Lara A. Ray, Kelly E. Courtney, Daniel Roche, and Karen Miotto
5. The Promise of Repetitive Transcranial Magnetic Stimulation to Treat Addiction; Rachel A. Rabin, Daniel M. Blumberger, Zafiris J. Daskalakis, Tony P. George, and Mera S. Barr
6. Neuroscience and Mindfulness-Based Interventions: Translating Neural Mechanisms to Addiction Treatment; Matthew R. Pearson, Corey R. Roos, David B. Brown, and Katie Witkiewitz
7. New Approaches to Treating Cannabis Dependence: From Neuroscience to Practice; Janna Cousijn and Francesca M. Filbey8. Morphometric Biomarkers of Addiction and Treatment Response; Teresa R. Franklin, Joel Mumma, Kanchana Jagannathan, Reagan R. Wetherill, and Anna Rose Childress
9. Neural Mechanisms Supporting the Regulation of Cigarette Craving; Stephen J. Wilson
10. Neuroeconomics: Implications for Understanding and Treating Addictive Behavior; David P. Jarmolowicz, Derek D. Reed, and Warren K. Bickel
11. Using Neuroimaging to Improve Emotion Regulation Treatments for Substance Use Disorders; Claire E. Wilcox and Bryon Adinoff
PART III: TRANSLATIONAL APPROACHES WITH ADOLESCENTS
12. Introduction to Functional Brain Connectivity: Potential Contributions to Understanding Adolescent Vulnerability to Substance Abuse; Monique Ernst, Elizabeth A. Hale, Nicholas Balderston, Salvatore Torrisi
13. Approaching Adolescent Substance Abuse Treatment through Neuroscience; Anita Cservenka, Tam T. Nguyen-Louie, Susan F. Tapert, and Bonnie J. Nagel
14. Prenatal Exposure to Maternal Cigarette Smoking, Addiction and the Offspring Brain; Tomáš Paus and Zdenka Pausova
15. Deconstructing the Neural Substrates of Motivational Interviewing: A New Look at Unresolved Questions; Sarah W. Feldstein Ewing, Hollis Karoly, and Jon M. Houck
16. Neural Influences in Contingency Management for Adolescent Substance Use; Catherine Stanger and Hugh Garavan
PART IV: EPILOGUE
17. How to Practically Apply Lessons Learned from Translational Neuroscience to Intervention Development: Ideas for the Road Ahead; Sarah W. Feldstein Ewing, Katie Witkiewitz, and Francesca M. Filbey
| Erscheint lt. Verlag | 16.7.2015 |
|---|---|
| Zusatzinfo | XXI, 270 p. |
| Verlagsort | Basingstoke |
| Sprache | englisch |
| Maße | 140 x 216 mm |
| Themenwelt | Geisteswissenschaften ► Psychologie ► Biopsychologie / Neurowissenschaften |
| Geisteswissenschaften ► Psychologie ► Klinische Psychologie | |
| Geisteswissenschaften ► Psychologie ► Persönlichkeitsstörungen | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Suchtkrankheiten | |
| Naturwissenschaften | |
| ISBN-10 | 1-137-36264-2 / 1137362642 |
| ISBN-13 | 978-1-137-36264-3 / 9781137362643 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
